Experience
University of Western Australia
Academisch Ziekenhuis Leiden
Member of team that represented Sarepta and University of Western Australia in Federal Circuit appeals from interferences related to Exondys 51® (eteplirsen) for Duchenne muscular dystrophy.
University of Western Australia v. Academisch Ziekenhuis Leiden, 16-1937, -2086, Fed. Cir.
Academisch Ziekenhuis Leiden v. University of Western Australia
University of Western Australia
University of Western Australia v. Academisch Ziekenhuis Leiden
Sarepta Therapeutics
Trading Technologies, Inc. v. CQG, Inc.
Trading Technologies, Inc.
Hillcrest Laboratories, Inc. v. Movea, Inc.
Hillcrest Laboratories, Inc.
Cox Communications v. Sprint Communication Co.
Sprint Communication Co.
Ethicon Endo-Surgery, Inc. v. Covidien LP
Covidien LP
Nestle USA, Inc.
5th Market, Inc. v. Chicago Mercantile Exchange, Inc.
Chicago Mercantile Exchange, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.